<DOC>
	<DOC>NCT02013531</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of flexibly dosed adjunctive brexpiprazole treatment in subjects with major depressive disorder and anxiety symptoms, who are experiencing an inadequate selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI) response.</brief_summary>
	<brief_title>Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Main Have a diagnosis of a single or recurrent, nonpsychotic episode of MDD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSMIVTR) and confirmed by both the Mini International Neuropsychiatric Interview (M.I.N.I.) and an adequate clinical psychiatric evaluation. Have a treatment history of an inadequate ADT response to at least 1 ADT (but not &gt; 3) for the current episode. Have received a single, trialapproved, SSRI or SNRI at an adequate dose for ≥ 6 weeks prior to screening. Are 18 to 65 years old at the time of consent (inclusive, and outpatients only). Have a Hamilton Depression Rating Scale (HAMD)17item Total Score ≥ 18 at screening and baseline. Have a Hamilton Anxiety Rating Scale (HAMA) Total Score ≥ 20 at screening and baseline. Main Subjects with any of the following current Axis I DSMIVTR diagnoses: delirium dementia amnestic other cognitive disorders schizophrenia schizoaffective disorder other psychotic disorders bipolar I disorder, bipolar II disorder bipolar disorder not otherwise specified (NOS) eating disorders anorexia nervosa bulimia obsessive compulsive disorder posttraumatic stress disorder Subjects with any of the following current Axis II DSMIVTR diagnoses: borderline, antisocial paranoid schizoid schizotypal histrionic personality disorders mental retardation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Major depressive disorder</keyword>
	<keyword>Anxiety Symptoms</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>emotional withdrawal</keyword>
	<keyword>antipsychotic</keyword>
</DOC>